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Abstract
Purpose Bioengineered dermo-epidermal skin analogs
containing melanocytes represent a promising approach to
cover large skin defects including restoration of the
patient’s own skin color. So far, little is known about the
development of blood and lymphatic vessels in pigmented
skin analogs after transplantation. In this experimental
study, we analyzed the advancement and differences of
host blood and lymphatic vessel ingrowth into light- and
dark-pigmented human tissue-engineered skin analogs in a
rat model.
Methods Keratinocytes, melanocytes, and fibroblasts
from light- and dark-pigmented skin biopsies were isolated,
cultured, and expanded. For each donor, melanocytes and
keratinocytes were seeded in ratios of 1:1, 1:5, and 1:10
onto fibroblast-containing collagen gels. The skin analogs
were subsequently transplanted onto full-thickness wounds
of immuno-incompetent rats and quantitatively analyzed
for vascular and lymphatic vessel density after 8 and
15 weeks.
Results The skin analogs revealed a significant difference
in vascularization patterns between light- and dark-pig-
mented constructs after 8 weeks, with a higher amount of
blood vessels in light compared to dark skin. In contrast, no
obvious difference could be detected within the light- and
dark-pigmented group when varying melanocyte/keratino-
cyte ratios were used. However, after 15 weeks, the
aforementioned difference in blood vessel density between
light and dark constructs could no longer be detected.
Regarding lymphatic vessels, light and dark analogs
showed similar vessel density after 8 and 15 weeks, while
there were generally less lymphatic than blood vessels.
Conclusion These data suggest that, at least during early
skin maturation, keratinocytes, melanocytes, and fibro-
blasts from different skin color types used to construct
pigmented dermo-epidermal skin analogs have distinct
influences on the host tissue after transplantation. We
speculate that different VEGF expression patterns might be
involved in this disparate revascularization pattern
observed.
Keywords Melanocytes  Melanocyte/keratinocyte
ratio  Tissue-engineering  Light-/dark-pigmented
skin analog  Skin vascularization  Blood vessels 
Lymphatic vessels  Rat model
Introduction
The therapy of large full-thickness skin wounds, as e.g., in
massive burns, is often difficult due to their complex sys-
temic impact and also lack of sufficient autologous donor
skin. Theoretically, tissue-engineered full-thickness skin
analogs offer an important alternative to conventional
autologous skin grafts. For several years, our laboratory has
made substantial efforts to develop and characterize a tis-
sue-engineered dermo-epidermal skin equivalent [1–5].
Most recently, we reconstituted pigmented dermo-
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epidermal skin analogs from different pigmentation types
and achieved very satisfactory in vivo results restoring the
patients’ native skin color [5]. This strategy holds promise
for treatment of full-thickness skin defects as well as skin
pigmentation disorders [6] in that the transplanted skin not
only covers the defect, but also protects against ultraviolet
radiation and provides the original skin color.
It has been shown, that the skin of light- and dark-pig-
mented individuals exhibits numerous intrinsic physiolog-
ical differences. Montagna et al. reported that the epidermis
of black skin has more and larger singly distributed mel-
anosomes in keratinocytes, and contains more cell layers in
the stratum corneum than that of white skin [7]. The dermis
of black skin demonstrates more collagen fibrils, glyco-
proteins, and larger, more numerous fibroblasts, as well as
more apocrine and eccrine sweat glands than that of white
skin [8]. Moreover, black skin shows a higher density of
superficial (subepidermal) blood vessels as well as more
numerous, larger lymphatic vessels and more nerve fibers
than white skin [8]. Black subjects’ skin is also less sus-
ceptible to cutaneous irritation induced by either chemicals
or UV light and displays less erythema, less blood vessel
reactivity, and cutaneous blood flow than white skin
[9–12].
However, little is known about the development of
blood and lymphatic vessels in tissue-engineered pig-
mented skin analogs of different pigmentation types after
transplantation and, in particular, there is no data regarding
the aforementioned physiologic differences between black
and white skin.
In this experimental study, we investigated the differ-
ences of host blood and lymphatic vessel ingrowth into
human tissue-engineered skin analogs derived from light-
and dark-pigmented donor skin at 8 and 15 weeks after
transplantation in a rat model.
Materials and methods
Human skin samples
The investigation was conducted according to Declaration
of Helsinki principles and after acceptance of the ethic
commission of the Canton Zurich. Children’s parents gave
informed consent to use skin samples. The human foreskin
samples were obtained from light and dark skin pigmen-
tation types from patients 1 to 16 years of age. Human
epidermal keratinocytes, melanocytes, and dermal fibro-
blasts were isolated from the skin samples. Tissue samples
for histological examinations were embedded in paraffin or
in OCT compound (Sakura Finetek, Switzerland) and kept
at -20 C.
Isolation and culturing of primary cells
Keratinocytes and fibroblasts were isolated and cultured as
described by Pontiggia et al. [4] and Biedermann et al. [13]
and melanocytes as specified in Bottcher-Haberzeth et al.
[5].
Preparation of tissue-engineered skin analogs
Transwell cell culture plates in six-well format containing
inserts with 3.0 lm pore-size membranes (BD Falcon,
Switzerland) were used to prepare skin analogs [3]. To
reconstruct the dermal compartment, rat collagen type I
was mixed with 0.2 ml neutralization buffer containing
0.15 M NaOH and with 1 9 105 human dermal fibro-
blasts (passage 1–3). After 10 min polymerization at room
temperature and 45 min in an incubator at 37 C, the
dermal equivalents were grown for 7 days in Dulbecco’s
modified Eagle’s (DMEM) medium enriched with 10 %
FCS and Hepes (DMEM, Invitrogen, Switzerland). Sub-
sequently, 5 9 105 keratinocytes and melanocytes (pas-
sage 1–3) of the corresponding donor skin were seeded in
different ratios (melanocyte/keratinocytes 1:1, 1:5, or
1:10) onto dermal equivalents. The skin analogs were
cultured for 1 week in a 1:5 mix of melanocyte growth
medium (Promocell, Germany) and keratinocyte medium
(SFM, Invitrogen, Switzerland) and subsequently
transplanted.
Transplantation of cultured dermo-epidermal skin
analogs
All animal studies have been approved by the local com-
mittee for experimental animal research (permission
number: 76/2011). Immuno-deficient female nu/nu rats,
8–10 weeks old (Harlan Laboratories, Netherlands), were
anesthetized as previously described [14, 15]. Full-thick-
ness skin wounds were created on the backs of the rats.
Subsequently, custom-made steel rings (diameter 2.6 cm)
were sutured into the skin wounds using non-absorbable
polyester sutures (Ethibond, Ethicon, USA) and the skin
analogs were sutured into those rings. Steel rings protected
the skin analogs and prevented the closure of the wound by
the surrounding rat skin. The transplants were then covered
with a silicone foil (Silon-SES, BMS, USA), a polyure-
thane sponge (Ligasano, Ligamed, Austria), a cohesive
conforming bandage (Sincohaft, Theo Frey AG, Switzer-
land), and tape as wound dressing. Dressing changes and
photographic documentations were performed once per
week. After 8 (N = 20) or 15 (N = 9) weeks the trans-
planted skin analogs were excised in toto and processed for
paraffin- and cryosections.
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Histological analysis
Paraffin sections (5 lm) were stained with hematoxylin
and eosin (Sigma, Switzerland) to assess the histological
morphology.
Immunohistochemical staining
Immunofluorescence staining was performed as described
in Bottcher-Haberzeth et al. [15, 16]. Double immunoflu-
orescence stainings were performed to visualize rat blood
and/or lymphatic vessels (CD31 [clone TDL-3A12, 1:50,
BD Pharmingen, Switzerland], LYVE1 [polyclonal, 1:200,
Novus Biologicals, UK]), and human fibroblasts (CD90
[clone 5E10, 1:50, Dianova, Germany]). The human con-
trol skin samples were double stained for human CD31
[clone JC70A, 1:50, Dako, Switzerland], LYVE1 [clone
ab10278, 1:200, Abcam, UK]), and human fibroblasts
(CD90 [clone AS02, 1:50, Dianova, Germany]).
Pictures of immunofluorescence stainings were taken
with a DXM1200F digital camera connected to a Nikon
Eclipse TE2000-U inverted microscope. The device is
equipped with Hoechst 33342-, FITC-, and TRITC-filter
sets (Nikon AG, Switzerland; Software: Nikon ACT-1
vers. 2.70). Images were processed with Photoshop 7.0
(Adobe Systems Inc, Germany).
Fig. 1 Evaluation of normal
human foreskin and rat back
skin and the expression of
blood- and lymphatic-specific
markers. a, b Hematoxylin and
eosin staining showing a
comparison of normal human
versus rat skin; rat skin reveals
less layers in the epidermis and
abundant hair follicles in the
dermis. c, d
Immunofluorescence double
staining of human and rat skin
with antibodies against human
CD90 (staining of human
dermal compartment, green)
and against human and rat
CD31 (staining of blood vessels,
red). e, f Immunofluorescence
double staining of human and
rat skin with antibodies against
human and rat LYVE1
(lymphatic vessels, green) and
against human and rat CD31
(blood vessels, red),
distinguishing human and rat
lymphatic vessels (white
arrowheads) from blood vessels
(white arrows). LYVE1-
positive lymphatic vessels are
faintly positive for CD31 too;
however, blood vessels are
LYVE1 negative. Thus, LYVE1
was used as a lymphatic-specific
marker for all further
experiments. Cell nuclei are
stained with Hoechst (blue).
Scale bars 100 lm
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Rat blood and lymphatic vessel quantification
Vessel profiles in skin analogs were quantified on 6–8 lm
thick cryosections double stained for rat CD31/LYVE1 and
human CD90. Five random fields at 109 magnification
were counted in three different sections of each skin analog
after 8 or 15 weeks (n = 3–6). Vessel density was
expressed as the average number of blood/lymphatic ves-
sels from all fields counted in each skin analog. By double
staining for CD31 and LYVE1, it was possible to distin-
guish and separately quantify LYVE1-CD31? blood ves-
sels and LYVE1?CD31? lymph vessels. All results are
reported as mean ± standard deviation (± SD). Statistical
analysis was performed with GraphPad Prism 4.0 (Graph
Pad software, La Jolla, CA, USA). Comparison between
two groups was performed using the unpaired Student’s
t test. Results were considered significant with a P \ 0.05.
Results
Analysis of normal human and rat skin
Native human and rat skin show specific differences, as
demonstrated by a hematoxylin and eosin staining (Fig. 1a,
b). In comparison to human foreskin (Fig. 1a), rat back
skin (Fig. 1b) is composed of less epidermal layers. It also
contains hair follicles and sebaceous glands throughout the
dermis. To show the presence of human fibroblasts in the
dermal compartment of human skin, we used a human-
specific anti-CD90 antibody, which does not stain rat
fibroblasts (green, Fig. 1c, d). Human and rat blood ves-
sels, specifically labeled with the anti-human or -rat CD31
antibody (red, Fig 1c, d), were very abundant in the dermis
of both species.
To distinguish lymphatic vessels from blood vessels in
the skin, we used an antibody to stain LYVE1, a lymphatic
endothelium-specific marker (green, Fig. 1e, f). Both
human and rat blood vessels were LYVE1 negative;
however, lymphatic vessels also showed a faint CD31
staining.
Macroscopic appearance and epidermal structure
of human light- and dark-pigmented skin analogs
Eight weeks after transplantation the reconstructed human
skin analogs from light- and dark-pigmented donor skin
showed a strong resemblance to the donor skin regarding
color and structure, independent of which melanocyte/
keratinocyte ratio (1:1, 1:5, 1:10) was used (data not
shown). Pigmentation was homogenous throughout the
entire transplant of all specimens. Also, 15 weeks after
transplantation, light- and dark-pigmented skin analogs
prepared with a melanocyte/keratinocyte ratio of 1:5
showed macroscopically a light and dark aspect with
homogenous pigmentation (Fig. 2a, b). Microscopically,
both skin analogs showed a stratified and cornified epi-
dermis on a cellularized neodermis (Fig. 2a, b). However, a
Fig. 2 Tissue-engineered
human skin analogs constructed
with keratinocytes and
melanocytes (1:5 ratio) derived
from light or dark donor skin
15 weeks after transplantation.
Macroscopic aspect and
hematoxylin and eosin staining
of light- (a) and dark-pigmented
(b) skin analogs. The constructs
both demonstrate a macroscopic
and microscopic appearance
that, except for the absence of
rete ridges and skin appendages,
closely resemble normal human
light- and dark-pigmented skin.
Scale bars 100 lm
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noticeable difference between the two analogs was the
strongly pigmented basal layer of the dark skin analog
(Fig. 2b). Moreover, skin appendages and rete ridges were
absent in all engineered skin samples.
Blood vessel patterns of transplanted human tissue-
engineered skin analogs
Eight weeks post-transplantation, light- and dark-pig-
mented skin analogs prepared with different ratios of
melanocytes/keratinocytes (1:1, 1:5, 1:10) were excised
and analyzed. The human dermal compartment was
delineated by an anti-human CD90 staining (green, Fig. 3).
The ingrowth of host blood vessels into the human trans-
plants was analyzed using a staining against rat CD31 (red,
Fig. 3) and thereafter quantified (Fig. 4).
After 8 weeks, light- and dark-pigmented skin analogs
were entirely vascularized showing blood vessels
throughout the human CD90-stained dermal compartment
with a dense superficial vascular network underneath the
epidermis (Fig. 3). The quantification revealed that the
light-pigmented group contained a significantly higher
number of blood vessels than the dark-pigmented group
(Fig. 4a). However, the overall blood vessel density within
the light-pigmented group did not show any obvious dif-
ferences when varying melanocyte/keratinocyte ratios were
used: 50 ± 14 vessels/mm2 (1:1 ratio); 45 ± 8 vessels/
mm2 (1:5 ratio); 51 ± 8 vessels/mm2 (1:10 ratio). A sim-
ilar observation was made within the dark-pigmented
group: 31 ± 6 vessels/mm2 (1:1 ratio); 34 ± 8 vessels/
mm2 (1:5 ratio); 34 ± 11 vessels/mm2 (1:10 ratio)
(Fig. 4a).
Fig. 3 Host vascularization of
light- and dark-pigmented skin
analogs (melanocyte/
keratinocyte ratio 1:1, 1:5, 1:10)
8 weeks after transplantation. a,
c, e Rat blood vessels of light
skin are stained with an
antibody against rat CD31 (red).
b, d, f Rat blood vessels of dark
skin are stained with an
antibody against rat CD31 (red).
Human dermal compartment is
delineated by an anti-human
CD90 staining (green), and cell
nuclei with Hoechst (blue).
Light- and dark-pigmented skin
analogs show ubiquitous and
abundant blood vessels
throughout the human CD90-
stained neodermis. Scale bars
100 lm
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After 15 weeks, significantly fewer blood vessels were
detected in both light- and dark-pigmented skin analogs
(melanocyte/keratinocyte ratio 1:5). The light-pigmented
analogs contained 23 ± 10 vessels/mm2 and the dark-
pigmented analogs 25 ± 6 vessels/mm2 (Figs. 5a, b, 6a).
Lymphatic vessel patterns of transplanted human
tissue-engineered skin analogs
Eight weeks after transplantation, the human skin analogs
were analyzed for the presence of lymphatic, LYVE1-
positive, vessels in the human CD90-stained neodermis and
quantified (Fig. 4b). The lymphatic vessels were randomly
distributed throughout the human dermal compartment, but
were rare in close proximity to the dermo-epidermal
junction. They displayed an irregular shape and were
slightly larger in diameter than blood capillaries. More-
over, ingrowth was established 5 weeks post-transplanta-
tion as compared to blood vessel networks, which were
already completely established after 3 weeks in vivo (data
not shown).
After 8 weeks, we did not detect any statistically sig-
nificant difference in the lymphatic vessel densities
between varying melanocyte/keratinocyte ratios of light-
[6 ± 3 vessels/mm2 (1:1 ratio); 7 ± 3 vessels/mm2 (1:5
ratio); 9 ± 3 vessels/mm2 (1:10 ratio)] and dark-pigmented
group [9 ± 3 vessels/mm2 (1:1 ratio); 9 ± 5 vessels/mm2
(1:5 ratio); 8 ± 4 vessels/mm2 (1:10 ratio)]. Of note, they
occurred at a much lower density as compared to blood
vessels (Fig. 4b).
The number of lymphatic vessels did not change after
15 weeks post-transplantation and was comparable to the
amount at 8 weeks in both light- (7 ± 3 vessels/mm2) and
dark-pigmented skin analogs (9 ± 4 vessels/mm2) (both
1:5 ratio) (Figs. 5c, d, 6b).
Discussion
To the best of our knowledge, this is the first study inves-
tigating the blood and lymphatic vessel patterns in differ-
entially pigmented human tissue-engineered skin analogs at
8 and 15 weeks after transplantation. In particular, we ana-
lyzed quantitative differences in revascularization patterns
between light- and dark-pigmented skin analogs. Overall,
our study demonstrates distinctly disparate blood vessel
densities in the early wound-healing stages at 8 weeks post-
transplantation between the light- and the dark-pigmented
groups. Interestingly, this clear differences can no longer be
observed at a later stage, namely at 15 weeks post-trans-
plantation. Of note, these differences cannot be seen
regarding lymph vessel ingrowth. Some aspects deserve to
be addressed in more detail.
The fact that we observe a disparate vascularization
pattern between light- and dark-pigmented constructs 8
weeks after transplantation, with a significantly higher
amount of blood vessels in the light- compared to the dark-
pigmented skin analog group, is clearly surprising. Little is
known about differences concerning blood and/or lym-
phatic vessel densities in light and dark-pigmented human
skin. What has already been described is that the facial skin
of dark-pigmented individuals contains a higher density of
superficial blood vessels than the facial skin of light-pig-
mented persons [8]. Of note, dark skin is less susceptible to
different chemical irritants, most probably due to decreased
blood vessel reactivity and therefore less cutaneous blood
Fig. 4 The density of rat blood and lymphatic vessels in light- and
dark-pigmented skin analogs (melanocyte/keratinocyte ratio 1:1, 1:5,
1:10) 8 weeks after transplantation. a Blood vessel (CD31) density of
light- (white bars) and dark-pigmented analogs (black bars). Note a
significantly higher number of blood vessels in the light- than the
dark-pigmented group. b Lymphatic vessel (LYVE1) density of light-
(white bars) and dark-pigmented analogs (black bars). Of note,
lymphatic vessel ingrowth occurred at a much lower density as
compared to blood vessels, regardless of the pigmentation pattern.
Table shows values as the mean (± SD) number of rat blood (a)/
lymphatic (b) vessels quantified per mm2. N = 3 or 4 for each group
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flow [9–12]. Our results from 8 weeks after transplantation
do not demonstrate a vascularization pattern reflecting this
distinct physiological morphology, but rather show the
opposite. We hypothesize, that this time point might be too
early for skin analogs to show distinct differences as seen
in a physiological, i.e., homeostatic situation. Another
explanation could be that the differences between dark and
light facial skin reported by Montagna et al. [8] might
simply not be present in light and dark foreskins as used in
our study, because these cells exhibit diverse angiogenic
characteristics. Indeed, when analyzing native light and
dark foreskin samples, we were not able to detect any
apparent differences regarding blood vessels or VEGFA
expression patterns (data not shown). Nonetheless, the fact
that we observe significant differences in the early, i.e.,
probably not yet homeostatic, vascular pattern between
light- and dark-pigmented skin analogs, suggests that
intrinsic signals stemming from keratinocytes, melano-
cytes, or fibroblasts must be responsible for this transient
phenomenon.
Interestingly, 15 weeks post-transplantation no more
differences could be detected in the number of vessels
present in light and dark grafts. We propose the following
interpretation for this change from 8 to 15 weeks. Shortly
after transplantation, skin tissue needs to be quickly re-
vascularized to ensure cell survival and adequate integra-
tion of the transplant into the host tissue [17, 18]. Later, as
the graft matures and reaches the remodeling stage, the
initially needed, but now redundant, vascular networks are
reduced [19, 20].
Fig. 5 Host blood and
lymphatic vessels in light and
dark skin analogs (melanocyte/
keratinocyte ratio 1:5) 15 weeks
after transplantation. Rat blood
vessels of light- (a) and dark-
pigmented (b) skin analogs are
stained with an antibody against
rat CD31 (red). Differentially
pigmented skin analogs show
similar blood vessel patterns
throughout the human CD90-
stained neodermis (green).
Lymphatic vessels of light
(c) and dark (d) skin analogs
stained with LYVE1 (green)
appear at much lower density in
human CD90-dermal
compartment (red) as compared
to blood vessels. Cell nuclei are
stained with Hoechst (blue).
Scale bars 100 lm
Fig. 6 The density of rat blood and lymphatic vessels in light- and
dark-pigmented skin analogs (1:5 ratio) 15 weeks after transplanta-
tion. a Patterns of blood vessel (CD31) in light (white bars) and dark
analogs (black bars) do not reveal any statistically significant
difference. b Lymphatic vessel (LYVE1) patterns of light (white
bars) and dark analogs (black bars) are comparable and appear at
lower density than those of blood vessels. Table show values as the
mean (± SD) number of rat blood (a)/lymphatic (b) vessels quantified
per mm2. N = 3 or 4 for each group
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Of note, although we do notice the described, temporary
difference in the vascularization dynamics, all transplants
exhibit an apparently competent capillary network within
the dermal compartment, ensuring survival and, presum-
ably, also supporting maturation of the dermo-epidermal
skin analogs.
Regarding lymphatic vessels, we observe an equal
density at 8 and 15 weeks after transplantation. However,
their ingrowth occurs later and the number of lymphatic
vessels is clearly less compared to blood vessels. Interest-
ingly, an abundant rat blood capillary network can be
identified in the dermal compartment as early as 3 weeks
post-transplantation, whereas the beginning of lymphatic
vessel ingrowth in our skin analogs was seen only 5 weeks
after transplantation (data not shown). It is reasonable to
argue that the establishment of a rapid vascular supply
within the transplanted skin has the highest priority with
regard to immediate graft take and long-term survival, and
therefore occurs earlier than lymphatic vessel ingrowth. Of
note, Nogami et al. [21] followed the recovery of lymphatic
vessels in rat skin incision wounds up to 12 weeks and
found that lymphatic vessels were not present in the wound
area, but only in the surrounding intact tissue. In contrast,
we observed that lymphatic vessels regenerated ubiqui-
tously and abundantly in the dermis of our skin analogs
already 5 weeks after transplantation. Furthermore, previ-
ous reports showed that lymphatic regeneration across scar
tissues is severely impaired and that fibrosis in a wound can
be directly responsible for lymphedema formation due to
reduced lymphatic endothelial cell proliferation and
abnormal lymphatic microarchitecture [22, 23]. In light of
the above, our findings are particularly important with
regard to our planned clinical application of laboratory-
engineered skin substitutes. It appears tenable that a com-
petent lymphatic vessel supply will also develop when our
skin substitutes are autologously transplanted onto human
patients.
In summary and conclusion, this appears to be the first
article demonstrating that differently pigmented human tis-
sue-engineered dermo-epidermal skin analogs show a near
physiological ingrowth of both blood and lymphatic vessels
in a rat model. Further, our results suggest that different cells,
especially keratinocytes, melanocytes, and fibroblasts of
light- and dark-pigmented skin analogs seem to orchestrate
temporarily disparate vascularization patterns. It appears
likely that favorable blood and lymphatic vessels ingrowth
dynamics take place when autologous tissue-engineered skin
analogs are transplanted onto human patients.
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